Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer identifies targetable BRCA alterations and AR resistance mechanisms

H Tukachinsky, RW Madison, JH Chung… - Clinical Cancer …, 2021 - AACR
Purpose: Comprehensive genomic profiling (CGP) is of increasing value for patients with
metastatic castration-resistant prostate cancer (mCRPC). mCRPC tends to metastasize to …
被引用次数：133 相关文章

Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms

H Tukachinsky, RW Madison, JH Chung… - Clinical Cancer …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Purpose:</jats: title>< jats: p>
Comprehensive genomic profiling (CGP) is of increasing value for patients with metastatic …

Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer identifies targetable BRCA alterations and AR resistance mechanisms

H Tukachinsky, RW Madison, JH Chung… - … cancer research: an …, 2021 - experts.umn.edu
PURPOSE: Comprehensive genomic profiling (CGP) is of increasing value for patients with
metastatic castration-resistant prostate cancer (mCRPC). mCRPC tends to metastasize to …
[HTML] nih.gov

[HTML][HTML] Genomic analysis of circulating tumor DNA in patients with advanced prostate cancer identifies targetable BRCA alterations and AR resistance mechanisms

H Tukachinsky, RW Madison, JH Chung… - … cancer research: an …, 2021 - ncbi.nlm.nih.gov
Purpose: Comprehensive genomic profiling (CGP) is of increasing value for patients with
metastatic castration-resistant prostate cancer (mCRPC). mCRPC tends to metastasize to …

Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms …

H Tukachinsky, RW Madison, JH Chung… - … Cancer Research: an …, 2021 - europepmc.org
Purpose Comprehensive genomic profiling (CGP) is of increasing value for patients with
metastatic castration-resistant prostate cancer (mCRPC). mCRPC tends to metastasize to …

Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms

H Tukachinsky, RW Madison… - … : an official journal …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose Comprehensive genomic profiling (CGP) is of increasing value for patients with
metastatic castration-resistant prostate cancer (mCRPC). mCRPC tends to metastasize to …